Nephros, Inc. (NEPH) Financials
NEPH Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 11.9 million | 3.5 million |
| 2023-09-30 | 10.9 million | 2.3 million |
| 2023-06-30 | 10.4 million | 1.7 million |
| 2023-03-31 | 10.9 million | 2.0 million |
NEPH Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -312000 | 390000 |
| 2023-09-30 | 562000 | 149000 |
| 2023-06-30 | 226000 | 194000 |
| 2023-03-31 | 276000 | 319000 |
NEPH Net Income
No data available :(
NEPH Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 4.3 million | - | 1.8 million |
| 2023-09-30 | 4.6 million | - | 780000 |
| 2023-06-30 | 4.1 million | - | 857000 |
| 2023-03-31 | 3.8 million | - | 931000 |
NEPH Shares Outstanding
NEPH Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 75000 | 208000 | 2.4 million | - |
| 2023-09-30 | - | 205000 | 2.1 million | - |
| 2023-06-30 | - | 221000 | 2.2 million | - |
| 2023-03-31 | - | 239000 | 2.1 million | - |
NEPH Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 3.3 million | 1.3 million |
| 2023-09-30 | 3.7 million | 1.5 million |
| 2023-06-30 | 3.5 million | 1.5 million |
| 2023-03-31 | 3.7 million | 1.6 million |
NEPH
Price: $2.19
52 week price:
Earnings Per Share: -0.15 USD
P/E Ratio: -22.50
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 13441
Market Capitalization: 22.7 million